These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 13765363)
1. Bioassay of plasma levels of A-139 and mannitol mustard for use in determining blood levels during regional brain cancer perfusions. MAHALEY MS; MAHALEY J; WOODHALL B Cancer Chemother Rep; 1961 Apr; 11():33-40. PubMed ID: 13765363 [No Abstract] [Full Text] [Related]
2. [REPORT ON REGIONAL CHEMOTHERAPY IN CANCEROLOGY]. VELASCO RN Bol Trab Soc Cir B Aires; 1963 Sep; 47():552-4. PubMed ID: 14091333 [No Abstract] [Full Text] [Related]
3. Comparative clinical evaluation of two alkylating agents: mannitol mustard and cyclophosphamide (cytoxan). PAPAC R; PETRAKIS NL; AMINI F; WOOD DA J Am Med Assoc; 1960 Mar; 172():1387-91. PubMed ID: 14430240 [No Abstract] [Full Text] [Related]
4. [EXPERIMENTAL REGIONAL PERFUSION OF THE EXTREMITIES WITH CYTOSTATICS]. HUSVETI S; BESZNYAK I; KUDASZ J Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():722-5. PubMed ID: 14120191 [No Abstract] [Full Text] [Related]
5. Selection of anti-cancer agents for regional brain cancer perfusion. MAHALEY MS; WOODHALL B; KNISELY WH Surg Forum; 1960; 10():774-7. PubMed ID: 14419931 [No Abstract] [Full Text] [Related]
6. [CLINICAL TESTING OF THE THERAPEUTIC EFFECT OF 1,6-BIS(2-MESYLOXYETHYLAMINO) 1,6-DIDESOXY-D-MANNITOL DI-HC1 (R 49)]. GRAF F; TAKACSI NAGY L Orv Hetil; 1964 Mar; 105():541-6. PubMed ID: 14138698 [No Abstract] [Full Text] [Related]
7. NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES. UJHAZY V; WINKLER A Neoplasma; 1965; 12():11-4. PubMed ID: 14278323 [No Abstract] [Full Text] [Related]
8. [Comparative studies on the effect of dimethanesulfonyl-D-mannitol and mannitol mustard on animal leukemia]. NEMETH L; GAL F Arzneimittelforschung; 1962 Feb; 12():197-8. PubMed ID: 14478984 [No Abstract] [Full Text] [Related]
9. Brain perfusion. WOODHALL B Cancer Chemother Rep; 1960 Dec; 10():11-3. PubMed ID: 13786533 [No Abstract] [Full Text] [Related]
10. Results of perfusion--neural tumors. WOODHALL B Cancer Chemother Rep; 1960 Dec; 10():93-8. PubMed ID: 13786537 [No Abstract] [Full Text] [Related]
11. An evaluation of plasma levels of alkylating agents during regional chemotherapeutic perfusions. MAHALEY MS; WOODHALL B J Surg Res; 1961 Nov; 1():285-90. PubMed ID: 14468420 [No Abstract] [Full Text] [Related]
12. A NEW BIOLOGIC REACTION OBSERVED WITH SECONDARY NITROGEN MUSTARDS NOR-HN2 (NSC-10873) AND MANNITOL MUSTARD (NSC-9698). WILLIAMSON CE; KIRBY JG; MILLER JI; SASS S; KRAMER SP; SELIGMAN AM; WITTEN B Cancer Chemother Rep; 1964 Sep; 41():47-9. PubMed ID: 14213142 [No Abstract] [Full Text] [Related]
13. EFFECT OF HEPARIN-BOUND ALKYLATING AGENTS AND ENZYME INHIBITORS ON NEOPLASTIC GROWTH. CSABA G; KOROESI J; HORVATH C; MOLD K; ACS T Neoplasma; 1964; 11():137-44. PubMed ID: 14160693 [No Abstract] [Full Text] [Related]
14. Experiences in vitro with cytostatic treatment. Gazsó L Minerva Neurochir; 1969; 13(3):257-9. PubMed ID: 5382576 [No Abstract] [Full Text] [Related]
15. Experimental and clinical studies in localized cerebral perfusion. WOODHALL B Bull Soc Int Chir; 1960 Oct; 19():578-85. PubMed ID: 13786534 [No Abstract] [Full Text] [Related]